Skip to main content

Follow-Up Care for Adult Medicaid Beneficiaries Who are Newly Prescribed an Antipsychotic Medication

CBE ID
3313
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of new antipsychotic prescriptions for Medicaid beneficiaries age 18 years and older who have completed a follow-up visit with a provider with prescribing authority within four weeks (28 days) of prescription of an antipsychotic medication.

        • 1.14 Numerator

          The percentage of Medicaid beneficiaries aged 18 years and older with new antipsychotic prescriptions who completed an outpatient follow-up visit with a provider with prescribing authority within 28 days of the new antipsychotic prescription fill. 

        • 1.15 Denominator

          New antipsychotic prescriptions for Medicaid beneficiaries aged 18 years and older.

        • Exclusions

          • Medicaid beneficiaries with an acute inpatient admission during the four-week follow-up period after prescription of an antipsychotic medication
          • Patients who expired within four weeks of new prescription date.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Behavioral Health and Substance Use Spring Cycle 2022
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward Organization Email
          Steward Organization Copyright

          Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. Lewin disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications.

          CPT(R) contained in the Measure specifications is copyright 2004–2016 American Medical Association.